Report #2898668

Received Jun 2, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: —
Recovered: Recovered
Vaccinated: May 28, 2026
Onset: May 28, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	—	LA

Symptoms (1)

Pyrexia

Symptom narrative

Fever; This non-serious case was reported by a other health professional via sales rep and described the occurrence of fever in a 50-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On 28-MAY-2026, the patient received Shingrix (left arm). On 28-MAY-2026, less than a day after receiving Shingrix, the patient experienced fever (Verbatim: Fever). On 29-MAY-2026, the outcome of the fever was resolved (duration 1 day). The reporter considered the fever to be related to Shingrix. The company considered the fever to be related to Shingrix. Additional Information: GSK Receipt Date: 29-MAY-2026 The patient had a subsequent dose of Shingrix and had fever. The batch number was not provided upon follow- up with the reporter.